Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High?

Analysts' mean price target for vTv Therapeutics (VTVT) implies 39.9% upside, indicating constructive sell-side sentiment. The article notes that while price targets are not always effective, broad agreement in raising earnings estimates suggests improving fundamentals and supports a positive outlook for the stock.

Analysis

Analysts' mean price target for vTv Therapeutics (VTVT) implies 39.9% upside, indicating constructive sell-side sentiment. The article notes that while price targets are not always effective, broad agreement in raising earnings estimates suggests improving fundamentals and supports a positive outlook for the stock.